Ignite Creation Date:
2024-05-05 @ 11:34 PM
Last Modification Date:
2024-10-26 @ 10:36 AM
Study NCT ID:
NCT01361386
Status:
COMPLETED
Last Update Posted:
2014-06-16
First Post:
2011-05-23
Brief Title:
Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Long-Term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Asia
Status:
COMPLETED
Status Verified Date:
2014-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EPICOR ASIA
Brief Summary:
The purpose of this study is to describe the short-and long-tern ie up to 2 years following the index event AMPs in patients hospitalized for an acute coronary syndrome ie STEMI or NSTE-ACS and to document clinical outcomes economic aspects and impact on quality of life of these AMPs in a real-life setting
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None